Financials
- Fiscal year
- 2024
- Total assets
- €60,904
- Profit
- €27,855
- Solvency
- 49.3%
Pharmayat
ActiveSummary
The computed 12-month bankruptcy probability of Pharmayat is 3.1% (moderate). The 2024 annual accounts show equity of €30,022 and a net result of €27,855. Its solvency ranks better than 64% of 26062 sector peers (fiscal year 2024). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€60,904total assets 2024
- Equity
- €30,022
- Profit
- €27,855
Turnover not published (abridged schema)
Structure
Accounts 3 d early0 of 1 deed read
Why 52- Figures for FY 2024 (filed 28-07-2025)- Founded in 2024- Size: total assets €60,904+ Liquidity: current ratio 2.01, cash €12,145Show the evidence
Checked score
Score 2024
52
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 71% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength
Strong
Solvency
74
equity 49.3% of total assets
Liquidity
51
short-term debt 48.5% · cash 19.9%
Profitability
100
return on assets 45.7%
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2025: 0.7%
12-2025: 0.7%● 0.0% vs 11-2025
01-2026: 0.7%▼ -1.2% vs 12-2025lowest value
02-2026: 0.7%▲ +2.8% vs 01-2026
03-2026: 0.7%▲ +5.2% vs 02-2026
04-2026: 0.8%▲ +7.2% vs 03-2026
05-2026: 0.9%▲ +13.0% vs 04-2026
06-2026: 0.9%▼ -1.0% vs 05-2026
07-2026: 0.9%▲ +8.2% vs 06-2026
08-2026: 1.5%▲ +62.1% vs 07-2026
09-2026: 1.8%▲ +20.6% vs 08-2026
10-2026: 3.1%▲ +67.7% vs 09-2026highest value
- Figures for FY 2024 (filed 28-07-2025) raises the probability
- Founded in 2024 raises the probability for this profile
- Size: total assets €60,904 raises the probability for this profile
- Liquidity: current ratio 2.01, cash €12,145 lowers the probability
Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 2.01; short-term debt: 48.5% and cash: 19.9% of total assets), but 50.7% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 64%, liquidity 55%, profitability 96%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 06-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-07-2025, 3 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2024
3 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its 2024 accounts 3 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2025
- 28-07-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 17-10-2024
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.